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LEVELS of oestradiol receptors (ER) in
human breast cancer are routinely assayed
in many centres as a prognostic guide to
the postoperative hormonal control of
metastases. Between 50%0 and 70% of
primary tumours contain ER, and of
these, 50-60% respond favourably to
endocrine therapy (McGuire, 1975). About
half of the ER+ tumours fail to respond to
hormonal manipulations. The reason for
this is unclear. It is conceivable that the
receptors are defective in a way which
renders them incapable of mediating the
effects ofthe hormone. Such a defect might
exist at the level of transformation, trans-
location or chromatin binding of the
oestradiol-ER complex. Consequently, de-
tection of a gene product of oestrogen
action in conjunction with the measure-
ment of ER could provide a more reliable
index of the hormone responsiveness of a
tumour than the presence of ER alone.
The enzyme peroxidase (E.C. 1.11.1.7)
is a possible candidate for this role, since
it has been demonstrated in rat and
human mammary tumours (De Sombre
et al., 1975; Lyttle & De Sombre, 1977) and
oestrogen administration has been shown
to induce the enzyme in oestrogen-
sensitive tissues (Lyttle & De Sombre,
1977) Thus, peroxidase has been suggested
as a marker for tissues showing growth
dependence on oestrogens (Anderson et al.,
1975). In this study the presence of
peroxidase was correlated with the pre-
sence ofER in 130 breast caineers.
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Breast cancer tissue removecl at opera-
tion was immediately frozen and stored
in liqutid N2 until assayed. Since tumours
might not be uniform throughout their
mass, the same sample of tissue was used
for both the ER and peroxidase deter-
minations. All procedures were carriecl out
at 4°C unless otherwise stated.
Thawed tissue was chopped finely and
homogeniized in 4 vol of ice-cold TED)
buiffer (1 5mAi ethylenediaminetetra-acetic
acid; 0 5mini dithiothreitol; 0OO1M Tris-
HCI buffer at pH 7.4) by means of 3 x 20-
sec bursts with an Ultra-Turrax homogen-
izer. The homogenate was centrifuged for
1 h at 50,000 q. The supernatant was
assayecd for ER, while the pellet was
extracted for measurement of peroxidase
activity.
ER content was determined by the
method of Levin et al. (1978). 200 Iul
aliquots of supernatant were incubated
in the presence of 5 different concentra-
tions of [3H] oestradiol (20-100 pg/ml) in
a final volume of 500 IA for 18 h at 4°C.
500 IA of cold TED buffer containing
0.00205% dextran and 0.25% charcoal
(DCC) were then added to each tube; the
tubes were vortexed and incubated at 40C
for 90 mim. The DCC was pelleted at
1,000 g for 15 min and 500 yI of super-
natant counted in a Paekard Tricarb
Spectrometer. A 5-point Scatchard plot
(Scatchard, 1949) was constructed for
eaclh sample and the binding affinity
for oestradiol (Kd) and the total numberOESTROGEN DEPENDENT BREAST CANCER
of receptors (expressed as fmol [3H]-
oestradiol bound/mg cytosol protein) cal-
culated. Competitive binding analysis
(Leung et al., 1973) was also carried out
for each sample to establish the oestradiol-
binding index. The receptor assay was
regarded as positive if the results showed
a Scatchard plot, a Kd < 10-10M, > 3fmol
[3H] oestradiol bound/mg protein and a
binding index > 12%.
Peroxidase assay.-The pellet from the
initial 50,000 g x 60 min spin was resus-
pended in 4 vol of ice-cold hypertonic
extraction buffer (1*2M NaCi; 0OO1M Tris-
HCI buffer, pH 7.2) by means of 3 x 20-sec
bursts with an Ultra-Turrax homogenizer.
The suspension was centrifuged at 39,000g
x 45 min to obtain the supernatant con-
taining solubilized peroxidase. Dithio-
threitol is known to inhibit peroxidase in a
reversible fashion (De Sombre & Lyttle,
1978). Control experiments in which
dithiothreitol was omitted from the TED
buffer showed a negligible residual effect
of the dithiothreitol on the solubilized
peroxidase. The peroxidase activity of the
hypertonic supernatant was assayed by
the method of Lyttle & De Sombre (1977).
Between 20 and 200 [L of hypertonic
supernatant was added to the reaction
mixture (0013M guaiacol, 1 2M NaCi,
0-33mM H202, O-O1M Tris-HCI at pH 7-2)
in a final volume of 3 ml. The reaction
rate at 30°C was followed by recording the
absorbance change at 470 nm in a Gilford
Spectrophotometer against a blank from
which H202 was omitted. Peroxidase
activity was expressed as nmol tetra-
guaiacol formed/mg protein/min. Protein
concentrations were determined by the
Lowry method, with bovineserum albumin
as standard. Using the above method,
nmore than 9500 of the total peroxidase
activity was found in the hypertonic
supernatant, and only minimal amounts
( < 50 ) associated with the original cyto-
sol and residual particulate fractions.
Normal and hyperplastic breast tissue
(obtained from women undergoing cos-
metic surgery) possessed negligible per-
oxidase activity. Thus the peroxidase
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TABLE I-Distribution of peroxidase acti-
vity in breast tumours with and without
ER
Receptor
status
ER+
ER-
No. of
tumours
78
52
% Per-
oxidase+
65
71
assay was considered positive at the lowest
level distinguishable from the blank (1.0
nmol tetraguaiacol formed/mg protein/
min).
Using the criteria described above, ER
was found in 60% of tumours (Table I).
65% of ER+ tumours showed detectable
peroxidase activity while 710% of the ER-
tumours were peroxidase+. Thus no cor-
relation was found between the presence
of ER and peroxidase activity. The data
were further analysed in terms of the
histological diagnosis of tumour type.
Three main categories of tumours were
considered: adenocarcinoma, duct-cell
carcinoma and undifferentiated or ana-
plastic carcinoma. There were no sig-
nificant differences in ER and peroxidase
distributions among the 3 groups (Table
II). In addition, some tumours showing
TABLE II.-Histology, receptor status and
peroxidase activity in 43 breast tumours
Tumour type
ER+ adenocarcinoma
ER- I,,
ER+ duct-cell carcinoma
ER- ,, .. ..
ER+ anaplastic carcinoma
ER-
No. of
tumotirs
14
5
7
5
10
2
00 Per-
oxi(dase+
tuimours
71
60
57
60
50
100
heavy mononuclear-cell infiltration
(medullary carcinomas) were peroxidase-.
It is therefore unlikely that the finding of
peroxidase activity in the absence of ER
is explicable solely by infiltration by
lymphocytes or other cell types.
Recently, a fairly good correlation
between the presence of ER and peroxi-
dase activity in human treast-carcinoma
tissue has been reported (Duffy & Duffy,
1977a). These workers found that 78% of
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Via. 1. Distribution of pleioxi(lase a(tivity
in 85 peroxidase+ tumouirs. Shla(de(e areas
represent tlie percerntage of ER toimours
in eachl group.
ER- tumours showed peroxidase activity,
whilst only 20% of ER- tumouirs were
peroxidase+. Our results do not support
these findings. In our stutdy, 65% of ER+
tumours were peroxidaset wlhilst 71 % of
ER- tumours had peroxidase activity
(Table I). This discrepancy is unlikely to
be due to different criteria for peroxidase
positivity, as 6:3% of tumours wvith high
levels of peroxidase activity were ER-
as opposed to :30o% of tumours at lower
levels of peroxidase activity (see Fig. 1).
However, it could be due to differences in
the procedures used to assay receptors
(Duffy & Duffy, 1977b; Feherty et al.,
1970). These workers incubated cvtosol
writh [3H]oestradiol at 30°C for 30 min,
whereas in our study cytosol was incuba-
ted with [3H]oestradiol at 40C for 18 h.
Also, wNe lhave adopted rather stringent
criteria for establishing a positive ER
assay. Thus, an ER assay was considered
positive if the resultrs showed a Scatchard
plot, a Kd of < 10-MIzl, a binding index
of > 12% and if > 3fmol [3H]oestradiol
was bound/mg cytosol protein. Duffy and
Duffy (1 977b) considered an assay positive
if > lOfmol [3H]oestradiol were bound/mg
protein, but had no other criteria.
There are several possible explanations
for the finding of high levels of peroxidase
activity in ER- turnouirs. Ouir method of
receptor assay measures oinly cytoplasmic
receptors; it is conceivable that wheni
relatively high levels of endogenous oes-
trogens are present in the tissues, inuclear
translocation of the hormone-receptor
complexes caused depletion ofthe ER pool
and a negative ER assay. Alternatively,
peroxidase might be induiced by other
hormones or by a mechanism independent
of hormone action. Thirdly, it is possible
that there are several types of peroxidase
in the tissue, only one of which is induced
by oestradiol. These possibilities are at
present under investigationi.
The true value of the peroxidase assay
in assessing the hormone responsiveness
of a breast cancer will only emerge when
it, is possible to correlate enzyme activity
with response to endocrine therapy. Clini-
cal follow-up studies of patients on suich
therapy are under way and we expect to
report, on this in the future.
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